The Utility of Serum CD152 Concentration as a Differential Biomarker in Hashimoto's Thyroiditis
Keywords:
Hashimoto’s, CD152, autoimmune disease, TSH, T3Abstract
Background: Hashimoto's disease is an autoimmune disorder that affects the thyroid gland. The thyroid gland, shaped like a butterfly, is located at the base of the neck, directly beneath the Adam's apple. The thyroid produces hormones that help to regulate a variety of body processes. An autoimmune illness occurs when the immune system attacks healthy tissues. In Hashimoto's disease, immune system cells cause the death of thyroid hormone-producing cells. Hypothyroidism is a common consequence of the condition.
Objectives: Aim of study is to investigating the levels of CD152 and its correlation TSH, T3 and T4 to provide the reference for the diagnosis of Hashimoto's.
Materials and Methods: This study included (80 patients “40 males and 40 females” with Hashimoto's and 40 healthy persons as control group). Five ml of blood were taken from all to assess T3, T4, TSH, Vitamin D and CD152 according to procedures that provide with kits. By SPSS v.29, all data were analyzed at P value equal or less than 0.5.
Results: The level of CD152 is higher in female group when compare with male group P- value 0.05, the ROC carve show the CD152 is greater than vitamin D and TSH and more specific to distinguish between the groups, In Hashimoto's thyroiditis patients, there was a link between CD152 and thyroid function tests.
Conclusion: It was concluding CD152 is depend alone is a novel biomarker to HT diagnosis, in addition there is correlation between CD152 and TSH, T3, T4.
References
1. Holmberg, D., Cilio, C. M., Lundholm, M., & Motta, V. (2005). CTLA-4 (CD152) and its involvement in autoimmune disease. Autoimmunity, 38(3), 225-233.
2. Caturegli, P., De Remigis, A., & Rose, N. R. (2014). Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmunity reviews, 13(4-5), 391-397.
3. Chen, A.; Huang, L.; Zhang, L. Helper T Cell 17 and Regulatory T Cell Levels in Peripheral Blood of Newly Diagnosed Patients with Autoimmune Thyroid Disease: A Meta-Analysis. Horm. Metab. Res. 2023, 55, 40–50, Erratum in Horm. Metab. Res. 2023, 55, e2. [Google Scholar] [CrossRef] [PubMed]
4. Salazar-Viedma, M.; Vergaño-Salazar, J.G.; Pastenes, L.; D’Afonseca, V. Simulation Model for Hashimoto Autoimmune Thyroiditis Disease. Endocrinology 2021, 162, bqab190. [Google Scholar] [CrossRef] [PubMed]
5. Klubo-Gwiezdzinska, J.; Wartofsky, L. Hashimoto thyroiditis: An evidence-based guide to etiology, diagnosis and treatment. Pol. Arch. Intern. Med. 2022, 132, 16222. [Google Scholar] [CrossRef] [PubMed]
6. Kucharska, A. M., Gorska, E., Wasik, M., & Pyrzak, B. (2010). Decreased CD4+ CD152+ T cell subset and its correlation with the level of antithyroid antibodies in children with chronic autoimmune thyroiditis. European journal of medical research, 15, 1-4.
7. Anjos S, nguyen A, ounissi-Benkalha h, tessler MC, Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic t-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 2002; 277: 46478-86.
8. Kucharska AM, Gorska e, Wasik M, demkow U. Altered expression of t lymphocyte surface markers in children with chronic autoimmune thyroiditis. J Pharmacol Physiol 2008; 59 Suppl 6: 375-82.
9. Radetti G, Gottardi e, Bona G, Corrias A, Salardi S, Loche S. the natural history of euthyroid hashimoto’s thyroiditis in children. J Pediatr 2006; 149: 827-32.
10. De Vries L, Bulvik S, Phillip M. Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up. Arch dis Child 2009; 94: 33-7.
11. Mazziotti G, Premawardhana LdKe, Parkes AB, Adams h, Smyth PPA, Smyth df, Kaluaraci Wn, Wijeyaratne Cn, Jayasinghe A, de Silva dGh, Lazarus Jh. evolution of thyroid autoimmunity during iodine prophylaxis - the Sri Lankan experience. eur J endocrinol 2003, 149: 103-10.
12. Hu, Y., Xu, K., Jiang, L., Zhang, L., Shi, H., & Cui, D. (2018). Associations between three CTLA-4 polymorphisms and Hashimoto's thyroiditis risk: an updated meta-analysis with trial sequential analysis. Genetic testing and molecular biomarkers, 22(4), 224-236.
13. Tokić, S., Štefanić, M., Karner, I., & Glavaš-Obrovac, L. (2017). Altered expression of CTLA-4, CD28, VDR, and CD45 mRNA in T cells of patients with Hashimoto’s thyroiditis—a pilot study. Endokrynologia Polska, 68(3), 274-828.
14. Kucharska, A. M., Gorska, E., Wasik, M., Pyrzak, B., & Demkow, U. (2009). Expression of CD152 (CTLA-4) in children with autoimmune thyroiditis and+ 49 A/G polymorphism of exon 1 of the CTLA-4 gene. J Physiol Pharmacol, 60(Suppl 5), 77-80.
